vs
Side-by-side financial comparison of GLOBAL INDUSTRIAL Co (GIC) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $345.6M, roughly 1.8× GLOBAL INDUSTRIAL Co). Royalty Pharma plc runs the higher net margin — 34.4% vs 4.2%, a 30.2% gap on every dollar of revenue. On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 3.4%).
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
GIC vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $345.6M | $622.0M |
| Net Profit | $14.6M | $214.2M |
| Gross Margin | 34.5% | — |
| Operating Margin | 5.7% | 62.4% |
| Net Margin | 4.2% | 34.4% |
| Revenue YoY | 14.3% | 4.8% |
| Net Profit YoY | 36.4% | 2.9% |
| EPS (diluted) | $0.37 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $345.6M | $622.0M | ||
| Q3 25 | $353.6M | $609.3M | ||
| Q2 25 | $358.9M | $578.7M | ||
| Q1 25 | $321.0M | $568.2M | ||
| Q4 24 | $302.3M | $593.6M | ||
| Q3 24 | $342.4M | $564.7M | ||
| Q2 24 | $347.8M | $537.3M | ||
| Q1 24 | $323.4M | $568.0M |
| Q4 25 | $14.6M | $214.2M | ||
| Q3 25 | $18.8M | $288.2M | ||
| Q2 25 | $25.1M | $30.2M | ||
| Q1 25 | $13.6M | $238.3M | ||
| Q4 24 | $10.7M | $208.2M | ||
| Q3 24 | $16.8M | $544.0M | ||
| Q2 24 | $20.3M | $102.0M | ||
| Q1 24 | $13.2M | $4.8M |
| Q4 25 | 34.5% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 34.3% | — |
| Q4 25 | 5.7% | 62.4% | ||
| Q3 25 | 7.4% | 70.1% | ||
| Q2 25 | 9.3% | 36.3% | ||
| Q1 25 | 5.7% | 94.0% | ||
| Q4 24 | 4.8% | 60.9% | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 7.6% | 50.2% | ||
| Q1 24 | 5.4% | -13.0% |
| Q4 25 | 4.2% | 34.4% | ||
| Q3 25 | 5.3% | 47.3% | ||
| Q2 25 | 7.0% | 5.2% | ||
| Q1 25 | 4.2% | 41.9% | ||
| Q4 24 | 3.5% | 35.1% | ||
| Q3 24 | 4.9% | 96.3% | ||
| Q2 24 | 5.8% | 19.0% | ||
| Q1 24 | 4.1% | 0.8% |
| Q4 25 | $0.37 | $0.49 | ||
| Q3 25 | $0.48 | $0.67 | ||
| Q2 25 | $0.65 | $0.07 | ||
| Q1 25 | $0.35 | $0.55 | ||
| Q4 24 | $0.28 | $0.46 | ||
| Q3 24 | $0.44 | $1.21 | ||
| Q2 24 | $0.52 | $0.23 | ||
| Q1 24 | $0.34 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.5M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $313.2M | $9.7B |
| Total Assets | $580.8M | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.5M | $618.7M | ||
| Q3 25 | $67.2M | $938.9M | ||
| Q2 25 | $55.1M | $631.9M | ||
| Q1 25 | $39.0M | $1.1B | ||
| Q4 24 | $44.6M | $929.0M | ||
| Q3 24 | $38.9M | $950.1M | ||
| Q2 24 | $38.8M | $1.8B | ||
| Q1 24 | $29.9M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $313.2M | $9.7B | ||
| Q3 25 | $316.0M | $9.6B | ||
| Q2 25 | $305.2M | $9.5B | ||
| Q1 25 | $287.9M | $9.8B | ||
| Q4 24 | $281.1M | $10.3B | ||
| Q3 24 | $279.2M | $10.3B | ||
| Q2 24 | $270.4M | $9.8B | ||
| Q1 24 | $260.2M | $9.9B |
| Q4 25 | $580.8M | $19.6B | ||
| Q3 25 | $602.5M | $19.3B | ||
| Q2 25 | $586.5M | $18.3B | ||
| Q1 25 | $536.7M | $17.6B | ||
| Q4 24 | $520.7M | $18.2B | ||
| Q3 24 | $531.6M | $18.0B | ||
| Q2 24 | $542.5M | $17.7B | ||
| Q1 24 | $517.4M | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $827.1M |
| Free Cash FlowOCF − Capex | $19.2M | — |
| FCF MarginFCF / Revenue | 5.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 1.37× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $74.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | $827.1M | ||
| Q3 25 | $22.7M | $702.6M | ||
| Q2 25 | $31.7M | $364.0M | ||
| Q1 25 | $3.4M | $596.1M | ||
| Q4 24 | $15.9M | $742.5M | ||
| Q3 24 | $9.6M | $703.6M | ||
| Q2 24 | $18.8M | $658.2M | ||
| Q1 24 | $6.4M | $664.6M |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $22.0M | — | ||
| Q2 25 | $30.3M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $17.9M | — | ||
| Q1 24 | $5.1M | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 1.37× | 3.86× | ||
| Q3 25 | 1.21× | 2.44× | ||
| Q2 25 | 1.26× | 12.06× | ||
| Q1 25 | 0.25× | 2.50× | ||
| Q4 24 | 1.49× | 3.57× | ||
| Q3 24 | 0.57× | 1.29× | ||
| Q2 24 | 0.93× | 6.45× | ||
| Q1 24 | 0.48× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GIC
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
